| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 2818 |
| 1 | APIXABAN | 2525 |
| 2 | ABATACEPT | 2136 |
| 3 | INFLIXIMAB | 1638 |
| 4 | ALENDRONATE SODIUM | 1581 |
| 5 | RIVAROXABAN | 1551 |
| 6 | RISPERIDONE | 1525 |
| 7 | METHOTREXATE SODIUM | 1434 |
| 8 | PREDNISONE | 1427 |
| 9 | METHOTREXATE | 1392 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BEVACIZUMAB-AWWB | 109 | 0.1195 |
| 1 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 22 | 0.1000 |
| 2 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 199 | 0.0742 |
| 3 | RUCAPARIB | 423 | 0.0652 |
| 4 | ALOSETRON HYDROCHLORIDE | 43 | 0.0560 |
| 5 | CAFFEINE CITRATE | 36 | 0.0515 |
| 6 | PSEUDOEPHEDRINE HCL | 161 | 0.0441 |
| 7 | LEVODOPA AND CARBIDOPA | 434 | 0.0432 |
| 8 | DASATINIB | 1066 | 0.0415 |
| 9 | CORTISONE ACETATE | 180 | 0.0389 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 4377 |
| 1 | Factor Xa Inhibitor [EPC] | 4067 |
| 2 | Corticosteroid [EPC] | 2925 |
| 3 | Atypical Antipsychotic [EPC] | 2922 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2675 |
| 5 | Selective T Cell Costimulation Modulator [EPC] | 2136 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1883 |
| 7 | Benzodiazepine [EPC] | 1826 |
| 8 | Anti-epileptic Agent [EPC] | 1671 |
| 9 | Progestin [EPC] | 1577 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CTLA-4-directed Blocking Antibody [EPC] | 792 | 0.0298 |
| 1 | Selective T Cell Costimulation Modulator [EPC] | 2136 | 0.0247 |
| 2 | Folate Analog [EPC] | 1 | 0.0233 |
| 3 | Partial Opioid Agonist/Antagonist [EPC] | 1 | 0.0222 |
| 4 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 18 | 0.0204 |
| 5 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 26 | 0.0203 |
| 6 | Orexin Receptor Antagonist [EPC] | 192 | 0.0185 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1883 | 0.0184 |
| 8 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 606 | 0.0170 |
| 9 | Aromatic Amino Acid [EPC] | 680 | 0.0169 |